BMJ Group, a renowned global healthcare knowledge provider, has announced the launch of five new journals to address critical areas of medical research and innovation. These additions expand BMJ Group’s portfolio, which already includes more than 65 journals, furthering its commitment to supporting excellence in research and healthcare innovation through open access (OA) publishing.
The newly launched journals aim to address diverse medical fields and offer specialized platforms for groundbreaking research:
• BMJ Connections Clinical Genetics and Genomics: This journal serves as a dedicated OA platform for pioneering research in genetics and genomics, fostering advancements in this rapidly evolving field.
• BMJ Connections Oncology: With a focus on global oncology research, this journal provides open access to studies in clinical, scientific, and translational cancer research, aiming to accelerate progress in combating cancer.
• BMJ Digital Health & AI: Designed to explore the intersection of technology and healthcare, this journal is complemented by the BMJ Future Health initiative, which includes conferences, webinars, and podcasts dedicated to the transformative role of MedTech and artificial intelligence in medicine.
• JME Practical Bioethics: Addressing contemporary ethical dilemmas in healthcare, this journal provides critical insights to guide ethical decision-making in clinical practice.
• BMJ Immunology: Set to launch in 2025, this journal will operate under a hybrid publication model to meet the varying needs of the global immunology community while adhering to funder mandates.
The launch of these journals comes at a time when healthcare systems face unprecedented challenges, including the rise of chronic diseases and the integration of AI in clinical care. BMJ Group aims to provide reliable and specialized platforms to bridge the gap between cutting-edge research and practical application, empowering healthcare providers and policymakers worldwide.
BMJ Group continues to champion global accessibility to high-quality research. Through flexible OA and hybrid publishing models, the organization supports equitable knowledge dissemination, particularly in regions with limited access to subscription-based journals. By offering gold and green OA options, BMJ Group enables researchers to share their findings promptly, fostering global collaboration and evidence-based improvements in healthcare.
As BMJ Group broadens its journal portfolio, its commitment to advancing medical science and supporting the medical community remains steadfast, driving innovation and excellence in research for the benefit of global healthcare.
Click here to read the original press release.
